tirzepatide breastfeeding study no longer contraindicated during Breastfeeding and GLP-1 Medications: Safety

It tells readers to raise persistent nausea, diarrhea or abdominal pain with their provider rather than making changes independently

For my patients with serious health challenges, this isnt a wellness trend

Administration of GLP-1 or GLP-1RAs (including exenatide, geniposide, liraglutide, lixisenatide, and semaglutide) enhances neurogenesis in the dentate gyrus, hippocampus, olfactory bulb, and medial striatum in animal models, while modulating apoptotic pathways and increasing animal survival under extreme factors [24]

While it can be uncomfortable, nausea from PT-141 is usually mild and improves over time as the body adjusts